Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001493152-21-017103

Options or other derivatives

  • Director acquired 451,467 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Diamond David Director 2021-07-08 Grant or award · Stock Options +451,467 451,467 D
Loading xslF345X03/ownership.xml…